Cargando…

Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions

Primary mediastinal large B-cell lymphoma (PMBCL) is a distinct clinicopathologic disease from other types of diffuse large B-cell lymphoma (DLBCL) with unique prognostic features and limited availability of clinical data. The current standard treatment for newly diagnosed PMBCL has long been depend...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Huan, Pan, Tao, He, Yizi, Zeng, Ruolan, Li, Yajun, Yi, Liming, Zang, Hui, Chen, Siwei, Duan, Qintong, Xiao, Ling, Zhou, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044947/ https://www.ncbi.nlm.nih.gov/pubmed/33869061 http://dx.doi.org/10.3389/fonc.2021.654854

Ejemplares similares

Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study
por: Duan, Qintong, et al.
Publicado: (2022)

Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis
por: Ou, Lijia, et al.
Publicado: (2023)

Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes
por: Pan, Tao, et al.
Publicado: (2021)

Ferroptosis-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Diffuse Large B-Cell Lymphoma
por: Chen, Huan, et al.
Publicado: (2021)

P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA
por: Zhou, Hui, et al.
Publicado: (2023)

Survival Analysis of Hepatosplenic T Cell Lymphoma: A Population-Based Study Using SEER
por: Li, Yajun, et al.
Publicado: (2021)

Successful Treatment of Primary CNS Extranodal NK/T-Cell Lymphoma with Surgery and Chemotherapy Combined with Sintilimab: A Case Report and Literature Review
por: Qin, Liping, et al.
Publicado: (2022)

High-dose methotrexate, thiotepa, orelabrutinib combined with or without rituximab in primary or secondary central nervous system diffuse large B-cell lymphoma: a single-center retrospective analysis
por: Li, Yufeng, et al.
Publicado: (2023)

Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up
por: Zhou, Hui, et al.
Publicado: (2020)

Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma
por: Nilak, Yash Dilip, et al.
Publicado: (2019)

Optimal Courses of Chemotherapy Combined with Radiotherapy for Low-Risk Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Propensity Score Matching Analysis
por: Li, Jin, et al.
Publicado: (2020)

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
por: Manne, Ashish, et al.
Publicado: (2021)

Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions
por: Lees, Charlotte, et al.
Publicado: (2019)

On the Importance of Individualized, Non-Coplanar Beam Configurations in Mediastinal Lymphoma Radiotherapy, Optimized With Automated Planning
por: Rossi, Linda, et al.
Publicado: (2021)

APOBEC3B: Future direction of liver cancer research
por: Yang, Xingyue, et al.
Publicado: (2022)

Precision Medicine in Lymphoma by Innovative Instrumental Platforms
por: Di Paolo, Antonello, et al.
Publicado: (2019)

Case Report: Primary Mediastinal Large B-Cell Lymphoma Invasion of Extranodal Thyroid Tissue Mimicking Tuberculosis and Confounded by Similar Ultrasonic Appearance
por: Wang, Ying, et al.
Publicado: (2022)

Noncoplanar intensity‐modulated radiation therapy for young female patients with mediastinal lymphoma
por: Chen, Xinyuan, et al.
Publicado: (2012)

T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions
por: Russler-Germain, David A., et al.
Publicado: (2023)

Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL)
por: Du, Jun, et al.
Publicado: (2023)

Primary refractory plasmablastic lymphoma: A precision oncology approach
por: Witte, Hanno M., et al.
Publicado: (2023)

Precision Breast-Conserving Surgery With Microwave Ablation Guidance: A Pilot Single-Center, Prospective Cohort Study
por: Pan, Hong, et al.
Publicado: (2021)

Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies
por: Decruyenaere, Philippe, et al.
Publicado: (2023)

A Primary Mediastinal Large B-Cell Lymphoma Patient With COVID-19 Infection After Intensive Immunochemotherapy: A Case Report
por: Li, Qiuhui, et al.
Publicado: (2020)

Precision diagnostics in chronic lymphocytic leukemia: Past, present and future
por: Mollstedt, John, et al.
Publicado: (2023)

Pediatric mediastinal lymphoma
por: Mallick, Saumyaranjan, et al.
Publicado: (2020)

Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma– a risk stratified analysis of the GHSG HD17 trial
por: Oertel, Michael, et al.
Publicado: (2023)

Case Report: Chemotherapy and Radiotherapy Combined With DC-CIK for Pulmonary and Mediastinal Metastases From Nasopharyngeal Carcinoma
por: Gan, Yi-Xiu, et al.
Publicado: (2022)

Skin Directed Therapy in Cutaneous T-Cell Lymphoma
por: Tarabadkar, Erica S., et al.
Publicado: (2019)

Advances in the treatment of Hodgkin lymphoma: Current and future approaches
por: Ullah, Fauzia, et al.
Publicado: (2023)

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
por: Su, Long, et al.
Publicado: (2022)

Giant mediastinal carcinoid
por: Jiwnani, Sabita, et al.
Publicado: (2015)

The Emerging Role of T-Cell Immunoglobulin Mucin-3 in Breast Cancer: A Promising Target For Immunotherapy
por: Cong, Yizi, et al.
Publicado: (2021)

Trends, Symptoms, and Outcomes of Resectable Giant Mediastinal Tumors
por: Shi, Xiaoshun, et al.
Publicado: (2022)

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
por: Zhong, Mengya, et al.
Publicado: (2021)

Mediastinal ganglioneuroma: An incidentaloma of childhood
por: Shukla, Ram Mohan, et al.
Publicado: (2013)

Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk
por: König, Laila, et al.
Publicado: (2020)

Radiation Metabolomics: Current Status and Future Directions
por: Menon, Smrithi S., et al.
Publicado: (2016)

Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives
por: Miyabayashi, Koji, et al.
Publicado: (2021)

Refractory primary mediastinal malignant germ cell tumor with multiple systemic metastases: A rare case report
por: Chen, Xiaoli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n0982e7a9un2ksd6jnnt8q11ia